ABOUT CASTOR
Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest-rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug-and-play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, eConsent, and real-world data capture. Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security, and reusability of data for researchers worldwide. For more information, visit www.castoredc.com.
FEATURED ARTICLES
-
Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.
-
Discover how integrating Patient-Reported Outcomes can drive alignment with Value-Based Care (VBC) principles, enhancing product marketability and adoption while promoting patient health and quality of life.
-
Learn how evolving with AI could potentially lead to more streamlined, efficient, and innovative drug development processes.
-
Learn how having a comprehensive understanding of regulatory perspectives on AI ethics will prove invaluable for researchers evaluating the integration of AI technology into their trials.
-
Closely examine the challenges of adoption, integration, and compliance measures involving eConsent and gain valuable insights for those contemplating their incorporation in clinical trials.
-
Gain a better understanding of the primary challenges faced by the life sciences industry's commercial model in response to the updated EU MDR guidelines.
-
Explore a broader strategy for shortening clinical trial timelines that encompasses various elements, ranging from enhancing interoperability to implementing AI-driven technologies.
-
See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.
-
Explore how biomarkers and digital endpoints address inefficiencies, significantly accelerating the pace of clinical trial processes, and have the potential to revolutionize medical research.
-
By increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.
-
Discover how innovative trial designs, the utilization of RWD and RWE, and the development of synthetic control arms are poised to drive advancements in the field of rare diseases.
-
As a result of trial design changes in the life sciences industry, learn what drug developers are doing to keep pace with the ongoing advancements in genomics, immunology, and precision medicine.
-
Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.
-
Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.
-
Discover ways that leveraged machine-to-machine devices connected directly to the Internet of Things could benefit clinical trials.
-
As wearables unleash new possibilities, the industry will need an effective strategy to utilize these useful tools. Consider these tips when incorporating wearables in a clinical study.
-
In May 2021, the EU MDR replaced the EU's Medical Device Directive and Directive on Active Implantable Medical Devices. Learn about the basics of this regulation, who it impacts, and how to collect EU MDR-compliant clinical data.
-
Explore all things EDC in this article: what it is, how researchers can use it in clinical trials, its numerous benefits, and examples of how these translate into the real world.
-
Explore why an AI algorithm needs a steady and significant stream of data to become more accurate and prove its efficacy in a clinical setting.
-
In order to have a successful clinical trial, researchers must recruit—and retain—patients. This is a struggle that researchers know well: only 1 in 20 patients who respond to a recruitment promotion complete the study, with only 1 in 5 showing up for initial screening.
CONTACT INFORMATION
Castor
175 Varick St.
New York, NY 10014
UNITED STATES
Contact: Laura McLoughlin